STRO financials

Sutro Biopharma (STRO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

STRO income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$102.48M–-$158.37M-$191.09M-22.49
2024$62.04M–-$238.45M-$227.46M-29.40
2023$153.73M–-$89.28M-$106.79M-17.68
2022$67.77M–-$128.94M-$119.20M-23.34
2021$61.88M–-$98.52M-$105.54M-22.74
2020$42.72M–-$71.06M-$32.13M-9.83